alakaAlaka Chatterjee

Alaka’s practice focuses on chemical, pharmaceutical and biotechnology patent prosecution.  In particular, Alaka has significant experience in preparing and prosecuting patent applications worldwide in the areas of solvent chemistry, organic chemistry, biochemistry, molecular biology, microbiology, bioinformatics, and immunology, including conditions relating to cancer, diabetes, neurodegeneration, infectious diseases, and technologies relating to solvent chemistry, stem cell biology, gene therapy, genomics and proteomics, RNA interference, antisense, protein therapeutics, antibodies, vaccines, small molecule therapeutics, and carbohydrate chemistry.

Alaka provides strategic patent counselling and worldwide patent portfolio management on behalf of a wide range of academic and corporate clients, including companies, universities and research institutions in the biotechnology, biomedical, pharmaceutical, agriculture, forestry and mining sectors.

Alaka is also experienced in due diligence analyses, and assessing and providing patentability, infringement, validity, and freedom-to-operate opinions. ​

Alaka’s research experience, both in academia and industry, in top research laboratories, together with a thorough understanding of patent rights, enables her to communicate and connect with scientists and researchers at a fundamental level and translate complex scientific concepts into patent applications.

Alaka is a registered patent agent and has a Ph.D. in Biochemistry from Tufts University, Boston, Massachusetts.  Alaka's doctoral work focused on the regulation of DNA replication. Her post-doctoral studies focused on cell cycle regulation at a Boston-area biotechnology company, and on insulin signalling at the Joslin Diabetes Center, Harvard Medical School, and at Tufts University.

Alaka also has a law degree from Suffolk University Law School in Boston, and provides legal consultancy services to Vanguard IP LLP through her law corporation.

Prior to founding Vanguard IP LLP, Alaka practiced at intellectual property law firms in Vancouver (Canada) and in Boston (USA) for over 15 years.